Patient Portal

Mark A. Schroeder, MD

Assistant Professor, Medicine
Medical Oncology, BMT and Leukemia

Specialty Areas

Bone Marrow Transplant
Hematology
Oncology
Hematologic Malignancies

Board Certifications

American Board of Internal Medicine, Medical Oncology
American Board of Internal Medicine
American Board of Internal Medicine, Hematology

Hospital Affiliations

Barnes-Jewish Hospital

Referral Information

Not Accepting New Patients

Areas of Clinical Interest

Oncology, cancer, bone marrow transplant, leukemia, MDS, graft-versus-host disease, transplant biology

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Office Phone: 314-454-8323
Fax: 314-454-7551

Siteman Cancer Center
Barnes-Jewish St. Peters Hospital

150 Entrance Way
St. Peters, MO 63376

Education

Education

Bachelor of Science: University of Toledo, Toledo, OH 1999
Medical Degree: University of Cincinnati, College of Medicine, Cincinnati, Ohio 2003
Residency, Internal Medicine: Barnes Jewish Hospital, St. Louis, MO 2006
Fellowship, Hematology and Oncology : Washington University School of Medicine, St. Louis, MO 2009
MS - Clinical Investigation: Washington University School of Medicine, St. Louis, MO 2012

Publication & Research

Publication & Research

Orthodontic traction of impacted maxillary canines using segmented arch mechanics.
Schroeder MA, Schroeder DK, Capelli Júnior J, Santos DJDS
Dental Press J Orthod. 2019; 24(5)79-89. doi: 10.1590/2177-6709.24.5.079-089.sar.

PMID:
    31721951
    [PubMed - in process]
Related citations


Glasdegib for the treatment of adult patients with newly diagnosed acute myeloid leukemia or high-grade myelodysplastic syndrome who are elderly or otherwise unfit for standard induction chemotherapy.
Goldsmith SR, Lovell AR, Schroeder MA
Drugs Today (Barc). 2019 Sep; 55(9)545-562. doi: 10.1358/dot.2019.55.9.3020160.

PMID:
    31584572
    [PubMed - indexed for MEDLINE]
Related citations


EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms.
Goldsmith SR, Fiala MA, O'Neal J, Souroullas GP, Toama W, Vij R, Schroeder MA
Clin Lymphoma Myeloma Leuk. 2019 Aug 30; pii: S2152-2650(19)31380-1. doi: 10.1016/j.clml.2019.08.010.

PMID:
    31551170
    [PubMed - as supplied by publisher]
Related citations


A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma.
Tuscano JM, Maverakis E, Groshen S, Tsao-Wei D, Luxardi G, Merleev AA, Beaven A, DiPersio JF, Popplewell L, Chen R, Kirschbaum M, Schroeder MA, Newman EM
Clin Cancer Res. 2019 Sep 3; doi: 10.1158/1078-0432.CCR-19-0438.

PMID:
    31481504
    [PubMed - as supplied by publisher]
Related citations


Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma.
Fiala MA, Vosuri V, Goldsmith S, Schroeder MA, Ghobadi A, Wildes TM, Stockerl-Goldstein KE, Vij R
Bone Marrow Transplant. 2019 Aug 28; doi: 10.1038/s41409-019-0663-5.

PMID:
    31462683
    [PubMed - as supplied by publisher]
Related citations


Quantifying inactive lithium in lithium metal batteries.
Fang C, Li J, Zhang M, Zhang Y, Yang F, Lee JZ, Lee MH, Alvarado J, Schroeder MA, Yang Y, Lu B, Williams N, Ceja M, Yang L, Cai M, Gu J, Xu K, Wang X, Meng YS
Nature. 2019 Aug; 572(7770)511-515. doi: 10.1038/s41586-019-1481-z.

PMID:
    31435056
    [PubMed - in process]
Related citations


Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.
Tew BY, Legendre C, Schroeder MA, Triche T, Gooden GC, Huang Y, Butry L, Ma DJ, Johnson K, Martinez RA, Pierobon M, Petricoin EF, O'Shaughnessy J, Osborne C, Tapia C, Buckley DN, Glen J, Bernstein M, Sarkaria JN, Toms SA, Salhia B
Neuro Oncol. 2019 Aug 21; pii: noz137. doi: 10.1093/neuonc/noz137.

PMID:
    31433055
    [PubMed - as supplied by publisher]
Related citations


An interview with Lincoln Issamu Nojima.
Nojima LI, Brunetto D, Valladares Neto J, Menezes LM, Schroeder MA, Matsumoto MAN
Dental Press J Orthod. 2019 Aug 1; 24(3)22-32. doi: 10.1590/2177-6709.24.3.022-032.int.

PMID:
    31390446
    [PubMed - in process]
Related citations


A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma.
Schroeder MA, Fiala MA, Huselton E, Cardone MH, Jaeger S, Jean SR, Shea K, Ghobadi A, Wildes T, Stockerl-Goldstein KE, Vij R
Clin Cancer Res. 2019 Jul 1; 25(13)3776-3783. doi: 10.1158/1078-0432.CCR-18-1909.

PMID:
    30952640
    [PubMed - in process]
Related citations


Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
Goldsmith SR, Fiala MA, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Schroeder MA, Tomasson M, Wildes TM, Vij R
Clin Lymphoma Myeloma Leuk. 2019 May; 19(5)285-289. doi: 10.1016/j.clml.2019.01.003.

PMID:
    30792096
    [PubMed - in process]
Related citations


Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer.
Schroeder MA, Ashami K, Staser K
Curr Protoc Pharmacol. 2018 Dec; 83(1)e47. doi: 10.1002/cpph.47.

PMID:
    30204297
    [PubMed - indexed for MEDLINE]
Related citations


Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Cortes JE, Douglas Smith B, Wang ES, Merchant A, Oehler VG, Arellano M, DeAngelo DJ, Pollyea DA, Sekeres MA, Robak T, Ma WW, Zeremski M, Naveed Shaik M, Douglas Laird A, O'Connell A, Chan G, Schroeder MA
Am J Hematol. 2018 Nov; 93(11)1301-1310. doi: 10.1002/ajh.25238.

PMID:
    30074259
    [PubMed - indexed for MEDLINE]
Related citations


Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Perry JSA, Russler-Germain EV, Zhou YW, Purtha W, Cooper ML, Choi J, Schroeder MA, Salazar V, Egawa T, Lee BC, Abumrad NA, Kim BS, Anderson MS, DiPersio JF, Hsieh CS
Immunity. 2018 Jun 19; 48(6)1271. doi: 10.1016/j.immuni.2018.05.011.

PMID:
    29924978
    [PubMed]
Related citations


Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
Kurokawa C, Iankov ID, Anderson SK, Aderca I, Leontovich AA, Maurer MJ, Oberg AL, Schroeder MA, Giannini C, Greiner SM, Becker MA, Thompson EA, Haluska P, Jentoft ME, Parney IF, Weroha SJ, Jen J, Sarkaria JN, Galanis E
J Natl Cancer Inst. 2018 Oct 1; 110(10)1123-1132. doi: 10.1093/jnci/djy033.

PMID:
    29788332
    [PubMed - indexed for MEDLINE]
Related citations


Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Perry JSA, Russler-Germain EV, Zhou YW, Purtha W, Cooper ML, Choi J, Schroeder MA, Salazar V, Egawa T, Lee BC, Abumrad NA, Kim BS, Anderson MS, DiPersio JF, Hsieh CS
Immunity. 2018 May 15; 48(5)923-936.e4. doi: 10.1016/j.immuni.2018.04.007.

PMID:
    29752065
    [PubMed - indexed for MEDLINE]
Related citations


A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.
Zeidan AM, Knaus HA, Robinson TM, Towlerton AMH, Warren EH, Zeidner JF, Blackford AL, Duffield AS, Rizzieri D, Frattini MG, Levy YM, Schroeder MA, Ferguson A, Sheldon KE, DeZern AE, Gojo I, Gore SD, Streicher H, Luznik L, Smith BD
Clin Cancer Res. 2018 Aug 1; 24(15)3519-3527. doi: 10.1158/1078-0432.CCR-17-3763.

PMID:
    29716921
    [PubMed - in process]
Related citations


Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
Choi J, Cooper ML, Staser K, Ashami K, Vij KR, Wang B, Marsala L, Niswonger J, Ritchey J, Alahmari B, Achilefu S, Tsunoda I, Schroeder MA, DiPersio JF
Leukemia. 2018 Nov; 32(11)2483-2494. doi: 10.1038/s41375-018-0123-z.

PMID:
    29691471
    [PubMed - indexed for MEDLINE]
Related citations


Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.
Zhou D, Alver BM, Li S, Hlady RA, Thompson JJ, Schroeder MA, Lee JH, Qiu J, Schwartz PH, Sarkaria JN, Robertson KD
Genome Biol. 2018 Mar 27; 19(1)43. doi: 10.1186/s13059-018-1420-6.

PMID:
    29587824
    [PubMed - indexed for MEDLINE]
Related citations


Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS.
Savona MR, Pollyea DA, Stock W, Oehler VG, Schroeder MA, Lancet J, McCloskey J, Kantarjian HM, Ma WW, Shaik MN, Laird AD, Zeremski M, O'Connell A, Chan G, Cortes JE
Clin Cancer Res. 2018 May 15; 24(10)2294-2303. doi: 10.1158/1078-0432.CCR-17-2824.

PMID:
    29463550
    [PubMed - in process]
Related citations


The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.
Schroeder MA, Choi J, Staser K, DiPersio JF
Biol Blood Marrow Transplant. 2018 Jun; 24(6)1125-1134. doi: 10.1016/j.bbmt.2017.12.797.

PMID:
    29289756
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Quintiles

Royalties:

Equity: No

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2019

Areas of Research Interest

Dr. Schroeder has a translational research focus in transplant biology and the development of novel therapeutics and treatment approaches for myelodysplastic syndrome and leukemia. His research in transplant biology includes improving stem cell mobilization; and, understanding and improvingtreatment of graft-versus-host disease. His clinical research interest includes hematologic malignancies, such as MDS, AML, and CLL; and, their treatment by hematopoietic stem cell transplantation and the development of new treatment approaches.